Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

<div>Nomogram for predicting 3-month all-cause mortality after TAVR. BNP, B-type natriuretic peptide; HR, heart rate; T-BIL, serum total bilirubin; NLR, neutrophil-to-lymphocyte ratio; CHD, coronary heart disease; TAVR, transcatheter aortic valve replacement.</div>

Journal of Interventional Cardiology

fig2

Figure 2

Figure 2: Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension 